Inflammation, Platelets and Sickle Cell Disease

Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Observational
SUMMARY

Sickle cell disease (SCD) is an autosomal recessive genetic disorder linked to a single mutation on beta-globin chains. This leads to red blood cell deformation and chronic hemolysis which can result in vaso-occlusive events, anemia and vasculopathy. Pathophysiology is incompletely understood, and beyond red blood cell's abnormalities this involves hemostasis and innate immunity. The aim of our study is to describe the mechanisms of thrombo-inflammation during the vaso-occlusive crisis (VOC) in adults with sickle cell disease.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 99
Healthy Volunteers: f
View:

• Patient with sickle cell disease diagnosis, hospitalized in emergency department and/or internal medicine department

• Patient older than 18 years

• Written consent to participate to the study

• Patient with health insurance

• Patient able to receive information about the study

Locations
Other Locations
France
IUCT-Oncopole University Hospital
RECRUITING
Toulouse
Contact Information
Primary
Pierre Cougoul, MD
cougoul.pierre@iuct-oncopole.fr
531156265
Backup
Sandra De Barros
debarros.s@chu-toulouse.fr
Time Frame
Start Date: 2023-01-15
Estimated Completion Date: 2025-12-30
Participants
Target number of participants: 25
Sponsors
Leads: University Hospital, Toulouse

This content was sourced from clinicaltrials.gov